Drugs / Flaxseed
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT05723458 | Jul 2023 → Jan 2024 | osteoarthritis, knee | Tabriz University of Medical Sciences | Unknown | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00275704 | May 2005 → Jun 2006 | — | Mayo Clinic | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flaxseed | “The present double-blind, randomized and placebo-controlled study will be conducted on patients with knee osteoarthritis to evaluate the safety and efficacy of a combined cream...” NCT05723458 ↗ |
| Route | Topical | “The cream will be administrated topically three times daily (9 AM, 3 PM, and 9 PM) for up to 12 weeks.” NCT05723458 ↗ |